Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PrecisionRNA Biotech (PreRNA) is a Hyderabad-based healthcare innovation company specializing in next-generation molecular diagnostics. The company's flagship product, CANTEL, is India's first microRNA-based blood test for breast cancer screening, designed to detect early molecular signals including Stage 0 (DCIS). By utilizing proprietary miRNA signatures and advanced bioinformatics, PreRNA provides a minimally invasive, accurate, and affordable alternative to traditional imaging methods like mammography. The company aims to democratize early cancer detection and integrate proactive screening into routine health check-ups across India.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Precision RNA Biotech.